CNS & neurological disorders drug targets最新文献

筛选
英文 中文
Inter/Transgenerational Effects of Drugs of Abuse: A Scoping Review. 药物滥用的代际/跨代影响:范围审查。
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/1871527321666220429122819
Mitra-Sadat Sadat-Shirazi, Mahsa Sadeghi-Adl, Ardeshir Akbarabadi, Ghorbangol Ashabi, Azarakhsh Mokri, Mohammad-Reza Zarrindast
{"title":"Inter/Transgenerational Effects of Drugs of Abuse: A Scoping Review.","authors":"Mitra-Sadat Sadat-Shirazi,&nbsp;Mahsa Sadeghi-Adl,&nbsp;Ardeshir Akbarabadi,&nbsp;Ghorbangol Ashabi,&nbsp;Azarakhsh Mokri,&nbsp;Mohammad-Reza Zarrindast","doi":"10.2174/1871527321666220429122819","DOIUrl":"https://doi.org/10.2174/1871527321666220429122819","url":null,"abstract":"<p><p>Drug addiction is a chronic relapsing disorder that makes it a global problem. Genetics and environmental factors are the two most important factors that make someone vulnerable to drug addiction. Investigations in the past decade highlighted the role of epigenetics in the inter/transgenerational inheritance of drug addiction. A growing body of evidence showed that parental (paternal, maternal, and biparental) drug exposure before conception changes the phenotype of the offspring, which is correlated with neurochemical and neurostructural changes in the brain. The current paper reviews the effects of parental (maternal, paternal, and biparental) exposure to drugs of abuse (opioids, cocaine, nicotine, alcohol, and cannabis) before gestation in animal models.</p>","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"22 4","pages":"512-538"},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9150442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology. g蛋白和gpcr介导的信号传导在神经病理生理中的作用。
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/1871527321666220430142722
Md Mominur Rahman, Sadia Afsana Mim, Md Rezaul Islam, Nasrin Sultana, Muniruddin Ahmed, Mohammad Amjad Kamal
{"title":"Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology.","authors":"Md Mominur Rahman,&nbsp;Sadia Afsana Mim,&nbsp;Md Rezaul Islam,&nbsp;Nasrin Sultana,&nbsp;Muniruddin Ahmed,&nbsp;Mohammad Amjad Kamal","doi":"10.2174/1871527321666220430142722","DOIUrl":"https://doi.org/10.2174/1871527321666220430142722","url":null,"abstract":"<p><p>G-protein-coupled receptors (GPCRs) are activated by manifold neurotransmitters, and their activation, in turn, evokes slow synaptic transmission. They are profoundly related to numerous psychiatric and neurological disorders such as schizophrenia and Parkinson's disease. The significant malady indications for GPCR modulators demonstrate a change towards obesity, diabetes, and Alzheimer's disease, while other central nervous system disorders persist highly represented. GPR52, GPR6, and GPR8 are recognised as orphan GPCRs, co-exist either with both the dopamine D2 and D1 receptors in neurons of the basal ganglia or with the dopamine D2 receptor alone, and recommend that between these orphan receptors, GPR52 has the maximum potential of being a therapeutic psychiatric receptor. Genetically modified creature models and molecular biological investigations have suggested that these improved GPCRs could be potential therapeutic psychiatric receptors. In this perspective, the role of molecular targets in GPCR-mediated signalling has been discussed that would be novel drug design and discovery options for a scientist to elaborate previous knowledge with modern techniques.</p>","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"22 1","pages":"2-5"},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9150443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety. 内源性大麻素系统作为诊断和治疗抑郁症和焦虑症的生物标志物。
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/1871527321666220405114402
Jocelyne Alcaraz-Silva, Daniel Feingold, Gerardo Viana-Torre, Henning Budde, Claudio Imperatori, Sérgio Machado, Eric Murillo-Rodríguez
{"title":"The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety.","authors":"Jocelyne Alcaraz-Silva,&nbsp;Daniel Feingold,&nbsp;Gerardo Viana-Torre,&nbsp;Henning Budde,&nbsp;Claudio Imperatori,&nbsp;Sérgio Machado,&nbsp;Eric Murillo-Rodríguez","doi":"10.2174/1871527321666220405114402","DOIUrl":"https://doi.org/10.2174/1871527321666220405114402","url":null,"abstract":"<p><strong>Background: </strong>Depression and anxiety belong to a family of mental disturbances that have increased significantly in recent years. The etiology of both disorders comprises multiple and complex factors, from genetic background to environmental influence. Since depression and anxiety present severe symptoms, they represent a greater clinical burden and greater therapeutic difficulty. Currently, standardized diagnostic procedures for depression and anxiety allow for the addition of further treatments, including psychotherapy and/or pharmacological intervention, with effective outcomes. However, further steps should be considered with regard to consideration of the endocannabinoid system's role in depression and anxiety.</p><p><strong>Objective: </strong>This study aimed to review the evidence from animal research and clinical studies on the role of cannabinoid receptors, the major endocannabinoids -anandamide (AEA) and 2-arachidonoylglycerol (2-AG)- and the enzymes related to the synthesis and degradation of these chemicals as putative biomarkers for diagnostic and therapeutic elements of depression and anxiety.</p><p><strong>Methods: </strong>This review included the online search, identification, and analysis of articles (basic and clinical trials) published in English in PubMed linked to the role of cannabinoid receptors, AEA, 2- AG, and the enzymes associated with the synthesis and degradation of these endocannabinoids in depression and anxiety.</p><p><strong>Results: </strong>The neurobiological relevance of the endocannabinoid system offers genetic or pharmacological manipulation of this system as a potential strategy for the diagnostic and clinical management of mood disorders, including depression and anxiety.</p><p><strong>Conclusion: </strong>Although the described approach in this review is promising, no solid evidence is yet available, and along with additional experiments using animal models that mimic human depression and anxiety, clinical trials are needed to explore the role of the endocannabinoid system's elements as well as the anandamide membrane transporter, none of which have been adequately studied in depression and anxiety.</p>","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"22 3","pages":"417-430"},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9157155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Importance of Pharmacophore in Designing Anticonvulsant Agents. 药效团在抗惊厥药物设计中的重要性。
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/1871527321666220401115529
Amol Kale, Rajendra Kakde, Smita Pawar, Vishal Jagtap, Rahul Dorgude
{"title":"Importance of Pharmacophore in Designing Anticonvulsant Agents.","authors":"Amol Kale,&nbsp;Rajendra Kakde,&nbsp;Smita Pawar,&nbsp;Vishal Jagtap,&nbsp;Rahul Dorgude","doi":"10.2174/1871527321666220401115529","DOIUrl":"https://doi.org/10.2174/1871527321666220401115529","url":null,"abstract":"<p><p>Drug design is one of the critical aspects of the drug development process. The present review focused on different heterocyclic molecules having anticonvulsant activity with structural diversity and common pharmacophoric features. For the first time (1995), Dimmock and his team introduced specific arrangements of three important pharmacophores for anticonvulsant activity. These pharmacophores include two hydrophobic binding sites and one hydrogen binding site. After a few years (2012), Pandeya modified Dimmock's concept by adding one more pharmacophoric feature as an electron donor in the previously suggested pharmacophoric arrangement of the anticonvulsant. As a result, numerous scientists designed anticonvulsant drugs based on Dimmock's and Pandeya's concept. In addition, marketed anticonvulsant preparation containing Riluzole, Phenobarbital, Progabide, Ralitoline, etc., also holds the suggested pharmacophores by Dimmock and Pandeya's pharmacophoric concept. This review mainly focuses on the compilation of reported scientific literature in the last decade on the pharmacophoric features of different heterocyclic anticonvulsants, which will help develop new anticonvulsants.</p>","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"22 4","pages":"500-511"},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9503602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Do Abnormalities in the Cerebrospinal Fluid Impact Neuropsychology with Progressing Age? 随着年龄的增长,脑脊液异常如何影响神经心理学?
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/1871527321666220408105130
Gargi Joshi, Anna Pick Kiong Ling, Soi Moi Chye, Rhun Yian Koh
{"title":"How Do Abnormalities in the Cerebrospinal Fluid Impact Neuropsychology with Progressing Age?","authors":"Gargi Joshi,&nbsp;Anna Pick Kiong Ling,&nbsp;Soi Moi Chye,&nbsp;Rhun Yian Koh","doi":"10.2174/1871527321666220408105130","DOIUrl":"https://doi.org/10.2174/1871527321666220408105130","url":null,"abstract":"<p><p>The behavior of an individual changes from neonate to elderly due to the development of the central nervous system (CNS). One of the important components of the CNS is the cerebrospinal fluid (CSF), which bathes the brain and spinal cord. CSF has changing properties throughout life, including composition and volume imbalance. However, a specific age group that shows prevailing abnormality- corresponding behavior remains unclear. The objective of this article is to explore how such changes reflect on one's psychological as well as physical processing. Production of CSF could be affected by many factors, including its flow, absorption, volume, and composition. Prenatally, congenital malformations and infections hold the greatest risk of impacting the child's physical and mental growth. In adolescents, transmission of external substances like alcohol or drugs in the cerebrospinal fluid is known to impact severe mood changes that potentially result in suicide and depression. In the adult working population, the influence of stress levels on CSF composition causes anxiety and sleep disorders. Finally, the reduced production of CSF was found to be associated with memory deficits and Alzheimer's disease in the aging group. From the collected evidence, it can be observed that CSF played an important role in behavioral changes and may be associated with neurodegenerations. By linking the CSF abnormalities to the clinical symptoms at different stages of life, it may provide additional information in the diagnosis of diseases that are associated with neuropsychological changes.</p>","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"22 3","pages":"431-440"},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9519347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traumatic Brain Injury in COVID-19 Patients with the Manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm. 以阵发性交感神经亢进和细胞因子风暴为表现的新冠肺炎患者外伤性脑损伤
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/1871527321666220420132616
Zeba Sami, Amaan Javed
{"title":"Traumatic Brain Injury in COVID-19 Patients with the Manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm.","authors":"Zeba Sami,&nbsp;Amaan Javed","doi":"10.2174/1871527321666220420132616","DOIUrl":"https://doi.org/10.2174/1871527321666220420132616","url":null,"abstract":"<jats:sec>\u0000<jats:title />\u0000<jats:p />\u0000</jats:sec>","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"22 6","pages":"786-788"},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9534278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase. 替莫唑胺耐药:o -6-甲基鸟嘌呤- dna甲基转移酶以外的多种机制综述。
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/1871527321666220404180944
Vanishree Rao, Gautam Kumar, R J A Vibhavari, Krishnadas Nandakumar, Nanasaheb Thorat, Mallikarjuna Rao Chamallamudi, Nitesh Kumar
{"title":"Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond <i>O</i>-6-Methylguanine-DNA Methyltransferase.","authors":"Vanishree Rao,&nbsp;Gautam Kumar,&nbsp;R J A Vibhavari,&nbsp;Krishnadas Nandakumar,&nbsp;Nanasaheb Thorat,&nbsp;Mallikarjuna Rao Chamallamudi,&nbsp;Nitesh Kumar","doi":"10.2174/1871527321666220404180944","DOIUrl":"https://doi.org/10.2174/1871527321666220404180944","url":null,"abstract":"<p><strong>Background: </strong>Chemotherapy with the oral alkylating agent temozolomide still prevails as a linchpin in the therapeutic regimen of glioblastoma alongside radiotherapy. Because of the impoverished prognosis and sparse chemotherapeutic medicaments associated with glioblastoma, the burgeoning resistance to temozolomide has made the whole condition almost irremediable.</p><p><strong>Objective: </strong>The present review highlights the possible mechanisms of drug resistance following chemotherapy with temozolomide.</p><p><strong>Methods: </strong>The review summarizes the recent developments, as published in articles from Scopus, PubMed, and Web of Science search engines.</p><p><strong>Description: </strong>One of the prime resistance mediators, O-6-methylguanine-DNA methyltransferase, upon activation, removes temozolomide-induced methyl adducts bound to DNA and reinstates genomic integrity. In the bargain, neoteric advances in the conception of temozolomide resistance have opened the door to explore several potential mediators like indirect DNA repair systems, efflux mechanisms, epigenetic modulation, microenvironmental influences, and autophagy-apoptosis processes that constantly lead to the failure of chemotherapy.</p><p><strong>Conclusion: </strong>This review sheds light on recent discoveries, proposed theories, and clinical developments in the field of temozolomide resistance to summarize the complex and intriguing involvement of oncobiological pathways.</p>","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"22 6","pages":"817-831"},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9542695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease. 糖尿病和阿尔茨海默病的机制和病因相似性:降糖药物是阿尔茨海默病的乐观治疗方法。
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/1871527321666220629162229
Subham Das, Anu K R, Debojyoti Halder, Saleem Akbar, Bahar Ahmed, Alex Joseph
{"title":"Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease.","authors":"Subham Das,&nbsp;Anu K R,&nbsp;Debojyoti Halder,&nbsp;Saleem Akbar,&nbsp;Bahar Ahmed,&nbsp;Alex Joseph","doi":"10.2174/1871527321666220629162229","DOIUrl":"https://doi.org/10.2174/1871527321666220629162229","url":null,"abstract":"BACKGROUND Diabetes mellitus and Alzheimer's disease are two common diseases that majorly affect the elderly population. Patients in both cases are increasing day by day. They are considered two independent diseases, but recent evidence suggests that they have a lot in common. OBJECTIVE In this review we focused on the connection between Alzheimer's disease and diabetes and highlighted the importance of antidiabetic drugs against Alzheimer's disease. METHODS Common pathways such as obesity, vascular diseases, oxidative stress, mitochondrial dysfunction, mutation of ApoE4 gene, and Sirtuin gene were found to manipulate both diseases. Antidiabetic drugs are found to have promising effects on Alzheimer's disease, acting by reducing insulin resistance, neuronal protection, and reducing amyloid-beta plaques. Some anti-diabetic drugs have shown promising results in vivo and in vitro studies. RESULTS No review present focuses on the structural features of the antidiabetic molecules against Alzheimer's disease, their crosslinking pathophysiology, the role of natural bioactive molecules, in silico advancements followed by preclinical and clinical studies, and current advancements. Hence, we concentrated on the factors mentioned in the objectives. CONCLUSION Alzheimer's disease can be considered a form of 'type-3 diabetes,' and repurposing the anti-diabetic drug will open up new paths of research in the field of Alzheimer's disease drug discovery.","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"22 7","pages":"973-993"},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9545882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Meet the Editorial Board Member 认识编辑委员会成员
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/187152732201220913121030
V. Di Marzo
{"title":"Meet the Editorial Board Member","authors":"V. Di Marzo","doi":"10.2174/187152732201220913121030","DOIUrl":"https://doi.org/10.2174/187152732201220913121030","url":null,"abstract":"<jats:sec> <jats:title /> <jats:p /> </jats:sec>","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"04 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86779937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Unani Polyherbal Formulations in the Treatment of Diseases with Special Reference to Neurodegenerative Disorders. 乌纳尼复方在治疗神经退行性疾病中的作用。
IF 3 4区 医学
CNS & neurological disorders drug targets Pub Date : 2023-01-01 DOI: 10.2174/1871527321666220127141611
Yasir Hasan Siddique
{"title":"Role of Unani Polyherbal Formulations in the Treatment of Diseases with Special Reference to Neurodegenerative Disorders.","authors":"Yasir Hasan Siddique","doi":"10.2174/1871527321666220127141611","DOIUrl":"https://doi.org/10.2174/1871527321666220127141611","url":null,"abstract":"<p><p>Unani system of medicine is based on the use of natural plant products. Unani polyherbal formulations (UPFs) are being prescribed for the treatment of various ailments. The preparations of the UPFs also required the animal products such as honey and umber. UPFs have been reported to cure various diseases but still lack scientific credibility. The Unani system is based on the holistic approach; the synergistic role of the compounds has been suggested to play a protective role against the illness. The present review has compiled the studies carried out on UPFs used to treat various diseases with special reference to neurodegenerative ailments. The exorbitant cost of conventional treatment has led the world to think towards alternative therapy with less cost and no or little side effects compared to conventional treatments. More research is required for UPFs on the experimental models along with the case controlled studies in order to establish UPFs in the mainstream of treatment.</p>","PeriodicalId":10456,"journal":{"name":"CNS & neurological disorders drug targets","volume":"22 3","pages":"321-328"},"PeriodicalIF":3.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9204218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信